Graeme J. Moyle

Corporate Officer/Principal at Chelsea & Westminster Hospital

60 year

Health Technology

Consumer Services

Profile

Graeme J.
Moyle is currently the Director-HIV Research Strategy at Chelsea & Westminster Hospital since 1994.
He previously worked as an Independent Director at Tobira Therapeutics, Inc. Dr. Moyle holds a doctorate degree from the University of Adelaide.

Graeme J. Moyle active positions

Companies	Position	Start
Chelsea & Westminster Hospital	Corporate Officer/Principal	1993-12-31

All active positions of Graeme J. Moyle

Former positions of Graeme J. Moyle

Companies	Position	End
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Director/Board Member	-

See the detail of Graeme J. Moyle's experience

Training of Graeme J. Moyle

University of Adelaide

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Graeme J. Moyle's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital